At June 30, 2026, the Company had a total remaining authorization of $14.5 billion related to the $20 billion share repurchase program authorized by the Board in 2025. Additionally, the Board has given the Company the general authorization to repurchase shares of its common stock withheld to satisfy employee withholding tax obligations related to stock-based compensation.



(In millions)	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
	Shares	Amount		Shares	Amount		Shares	Amount		Shares	Amount
Authorized stock repurchase programs	22	$	3,787	7	$	1,354	42	$	7,454	16	$	3,117
General authorization for shares withheld on stock award vesting	—	5		—	17		2	360		3	508
Total	22	$	3,792	7	$	1,371	44	$	7,814	19	$	3,625

The cash remitted for shares withheld on stock award vesting is included in financing activities in the Unaudited Consolidated Statements of Cash Flows and may differ from the aggregate cost of the shares withheld for taxes for each period due to the timing in remitting the taxes. As of June 30, 2026 and December 31, 2025, the Company recorded estimated liabilities of $70 million and $52 million, respectively, related to excise taxes on share repurchases, which are included in "Accrued expenses and other current liabilities" in the Consolidated Balance Sheets.

During the six months ended June 30, 2026 and 2025, the Board declared quarterly cash dividends of $0.42 and $0.38, respectively, per share of common stock and the Company paid $664 million and $631 million, respectively, in total cash dividends. In August 2026, the Board declared a cash dividend of $0.42 per share of common stock, payable on September 30, 2026 to stockholders of record as of the close of business on September 11, 2026.